Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Evelien L.J. Smits"'
Autor:
Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Jorrit De Waele, Christophe Hermans, Hilde Lambrechts, Bart Cuypers, Kris Laukens, Esther Bartholomeus, Vasiliki Siozopoulou, Winnok H. De Vos, Marc Peeters, Evelien L.J. Smits, Christophe Deben
Publikováno v:
Redox Biology, Vol 42, Iss , Pp 101949- (2021)
Auranofin (AF) is an FDA-approved antirheumatic drug with anticancer properties that acts as a thioredoxin reductase 1 (TrxR) inhibitor. The exact mechanisms through which AF targets cancer cells remain elusive. To shed light on the mode of action, t
Externí odkaz:
https://doaj.org/article/8e548721a8ab4a1db1e2e2ce64e19e4c
Autor:
Yannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon, Jorrit De Waele, Peter A. van Dam
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4, p 1807 (2021)
Even though cervical cancer is partly preventable, it still poses a great public health problem throughout the world. Current therapies have vastly improved the clinical outcomes of cervical cancer patients, but progress in new systemic treatment mod
Externí odkaz:
https://doaj.org/article/a56af4ececb4438b87a9a4c0e72597e5
Autor:
Peter A. van Dam, Marc Peeters, Eva Lion, Christof Vulsteke, Evelien L.J. Smits, Hans Prenen, Annelies Janssens, Sébastien Anguille, Kevin K. Ariën, Pieter Pannus, Maria E. Goossens, Bart Peeters, Debbie Le Blon, Lisa Verheggen, Elly Marcq, Greetje Vanhoutte, Lise Verbruggen, Laure-Anne Teuwen, Lieselot Croes, Timon Vandamme, Jonas R.M. Van Audenaerde, Yana Debie
Supplementary Figure 3: Gating strategy for a representative sample
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2741776c36345c050a0d66800abd6c49
https://doi.org/10.1158/1078-0432.22489859.v1
https://doi.org/10.1158/1078-0432.22489859.v1
Autor:
Peter A. van Dam, Marc Peeters, Eva Lion, Christof Vulsteke, Evelien L.J. Smits, Hans Prenen, Annelies Janssens, Sébastien Anguille, Kevin K. Ariën, Pieter Pannus, Maria E. Goossens, Bart Peeters, Debbie Le Blon, Lisa Verheggen, Elly Marcq, Greetje Vanhoutte, Lise Verbruggen, Laure-Anne Teuwen, Lieselot Croes, Timon Vandamme, Jonas R.M. Van Audenaerde, Yana Debie
Supplementary Tables S1-S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282f4a687bb9c01fc005f2df42cb5cd4
https://doi.org/10.1158/1078-0432.22489847.v1
https://doi.org/10.1158/1078-0432.22489847.v1
Autor:
Peter A. van Dam, Marc Peeters, Eva Lion, Christof Vulsteke, Evelien L.J. Smits, Hans Prenen, Annelies Janssens, Sébastien Anguille, Kevin K. Ariën, Pieter Pannus, Maria E. Goossens, Bart Peeters, Debbie Le Blon, Lisa Verheggen, Elly Marcq, Greetje Vanhoutte, Lise Verbruggen, Laure-Anne Teuwen, Lieselot Croes, Timon Vandamme, Jonas R.M. Van Audenaerde, Yana Debie
Purpose:Patients with cancer display reduced humoral responses after double-dose COVID-19 vaccination, whereas their cellular response is more comparable with that in healthy individuals. Recent studies demonstrated that a third vaccination dose boos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d35b81c8b11e3d31f5d0b584ab89ff8f
https://doi.org/10.1158/1078-0432.c.6533054
https://doi.org/10.1158/1078-0432.c.6533054
Autor:
Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Bart Peeters, Maria E. Goossens, Pieter Pannus, Kevin K. Ariën, Sébastien Anguille, Annelies Janssens, Hans Prenen, Evelien L.J. Smits, Christof Vulsteke, Eva Lion, Marc Peeters, Peter A. van Dam
Publikováno v:
Clinical cancer research
Purpose: Patients with cancer display reduced humoral responses after double-dose COVID-19 vaccination, whereas their cellular response is more comparable with that in healthy individuals. Recent studies demonstrated that a third vaccination dose boo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f575bbfaf9bcf3134856b5021f1a87c2
https://hdl.handle.net/10067/1925000151162165141
https://hdl.handle.net/10067/1925000151162165141
Autor:
Delphine Quatannens, Yannick Verhoeven, Peter Van Dam, Filip Lardon, Hans Prenen, Geert Roeyen, Marc Peeters, Evelien L.J. Smits, Jonas Van Audenaerde
Publikováno v:
Pharmacology and therapeutics
Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer related death. The urgent need for effective therapies is highlighted by the lack of adequate targeting. In PDAC, hedgehog (Hh) signaling is known to be aberrantly activated, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09cb3ab3ee2b3f785027245f9f3e1f4
https://pubmed.ncbi.nlm.nih.gov/34999181
https://pubmed.ncbi.nlm.nih.gov/34999181